Back to User profile » Dr Le-Qun Li
Papers published by Dr Le-Qun Li:
Commentary
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
Zhong J, Luo C, Zhang C, Li L
Journal of Hepatocellular Carcinoma 2017, 4:11-13
Published Date: 30 December 2016
Original Research
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection
Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ
OncoTargets and Therapy 2016, 9:6897-6907
Published Date: 10 November 2016
Original Research
Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis
Zhu SL, Zhong JH, Gong WF, Li H, Li LQ
OncoTargets and Therapy 2016, 9:2111-2119
Published Date: 15 April 2016
Letter
Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma
Zhong JH, Xiang BD, Li LQ
Drug Design, Development and Therapy 2015, 9:5623-5624
Published Date: 13 October 2015